BeyondSpring To Start China-U.S. Phase 3 Trial Of Novel Cancer Drug

BeyondSpring Pharmaceuticals, a clinical-stage cancer company, plans to start a China-US Phase III trial of its lead drug candidate, plinabulin, among patients with non-small cell lung cancer in Q1 of 2015. BeyondSpring, headquartered in New York City, is a virtual company. In plinabulin's Phase III trial, 75% of the patients will be enrolled in China and the remainder in the US.

Help employers find you! Check out all the jobs and post your resume.